The first human trial of corona vaccine in the United States was successful

Corona virus

The vaccine, developed to prevent coronavirus, has been tested in humans in the United States. This is the first human test in the United States. Satisfactory results have emerged from this test. Those who were vaccinated showed no side effects, as well as increased immunity to fight the coronavirus, the company that developed the vaccine, Moderna, said on Monday.

A trial of the first eight people concluded that the vaccine was safe and boosted the immune system. The tests began in March. Eight volunteers were given two doses of the vaccine. After the vaccination, the antibodies produced in the body of the volunteers were tested in the laboratory. The main thing is that this vaccine has been shown to be very effective in preventing the spread of the virus in the body. This was the most important thing for an effective vaccine.

In the second phase, Moderna will test the mRNA-1273 vaccine on 600 healthy volunteers. Half of the 600 volunteers will be in the age group of 18 to 55 years and the rest will be in the next age group of 55 years. The mRNA-1273 vaccine will boost the body’s immune system to fight the corona virus. In the third phase, 1,000 people will be tested in July. The FDA has approved Modern for the second phase.

Moderna Therapeutics, which conducts vaccine research on Covid-19, has quickly received the necessary approvals from the US Food and Drug Administration (FDA). NovaVax, an American company, will soon launch human trials of the vaccine. The Covid-19 vaccine is important to everyone right now. Around 100 researchers around the world are working to find a vaccine to prevent coronavirus. These vaccine projects are at different stages from research to clinical trials.